| INTRODUC TI ON
Impaired left ventricular diastolic function (LVDF) is a common finding in patients with type 2 diabetes mellitus (T2DM). Approximately 30% of individuals with T2DM manifest impaired LVDF without demonstrated coronary artery disease (CAD) or hypertension. [1] [2] [3] [4] The pressure difference between left atrium (LA) and LV during diastole is the result of LV relaxation and transmitral flow, followed by LA contraction at the end of diastole. Prominent features of diabetic myocardial dysfunction [5] [6] [7] include impaired LVDF with altered ventricular compliance and altered transmitral flow patterns during LV filling. [8] [9] [10] Abnormal LVDF develops in stages, starting with delayed relaxation, to pseudonormal filling and finally to restrictive filling. [11] [12] [13] [14] [15] Analysis of the transmitral velocity curve provides information about filling pressures and patient prognosis. 16 Transmitral flow is dependent on multiple interrelated factors including the rate and extent of ventricular relaxation, atrial and ventricular compliance, mitral valve displacement, suction factor and left atrial pressure. 17, 18 Transthoracic echocardiography (TTE) is routinely used to evaluate LVDF. [8] [9] [10] Parameters measured include pulse-wave Doppler transmitral blood flow and tissue Doppler imaging (TDI) of myocardial wall velocities, changes in LV volumes and pulmonary venous flow. 17, 18 The ratio of early mitral valve flow velocity (E) to the tissue Doppler early diastolic lengthening velocities (e') correlates closely with LV filling pressures. 19 Cardiac magnetic resonance imaging (CMRI) also can be used to measure blood flow alterations, including reduction in early diastolic filling rate (E velocity) and deceleration time (DecT), which is the gradual deceleration of the early LV filling time. [20] [21] [22] [23] Other parameters important to LVDF are the A wave and isovolumic relaxation time (IVRT), which are related to the higher effort expressed in late ventricular filling. 1, 4, 17 The aim of this study was to examine the relationship between parameters of diastolic function, measured with both CMRI and TTE, and glycemic control in T2DM patients.
| ME THODS

| Study population
Nineteen T2DM subjects and 21 age/gender/ethnicity-matched normal glucose-tolerant (NGT) control subjects participated in the study ( On the day of enrolment, weight, height, waist circumference, blood pressure and heart rate were recorded after 5 minutes of reclining.
Per cent body fat was determined by dual-energy X-ray absorptiometry (DEXA), as previously described. 24 
| Transthoracic echocardiography
TTE was performed in the standard parasternal long-and short-axis views and from apical orientations using a clinical system with a duplex 2. Tissue Doppler profiles were acquired in apical 4-chamber view to determine mitral septal peak velocity (e') and its relation to early diastolic velocity (E/e′) and left atrial diameter to help assess LV filling pressures.
The systolic and diastolic evaluations by echocardiography were performed by a single experienced echo-cardiographer (MMW) who was blinded to CMR results. The diagnosis of impaired LVDF was graded based on the ratio of the diastolic transmitral flow velocity (E) to the peak diastolic transmitral flow velocity (A) and deceleration time (DecT) as the main parameters. 6, 9, 10, 19 In patients with equivocal The diagnosis of impaired LVDF was graded as described in previous studies. 6, 9, 10, 20, [26] [27] [28] Adjustments were made for heart rate, age, body mass index (BMI), weight and body surface area (BSA).
| Cardiac MRI
CMR was performed on 3.0 T MRI system (TIM Trio, Siemens
Medical Solutions, Malvern, PA) with a six-channel phased-array torso coil and corresponding six posterior spine coil elements.
Standard cardiac two-, three-and four-chamber localizer views were obtained using a gradient-echo sequence (7 mm CMR data were analysed using dedicated software (CMR42, Circle Cardiovascular Imaging Inc., Calgary AB) to perform global and regional LV function analyses from short-axis images to determine LV volumes (trabeculae and papillary muscles included) and myocardial mass and cardiac output. Phase-contrast CMR images were processed to produce transmitral flow profiles. Body surface area (BSA) was calculated using the Mosteller formula. 
| Statistical analysis
Data are expressed as mean ± SD or percentages. Statistical analyses were performed using the R 3.4.2 statistical software (RStudio IDE, Version 1.0.153). Normality of data was assessed using the Shapiro-Wilk test. Student's t test was used to evaluate the null hypothesis between the NGT and T2DM groups for continuous variables, with P < .05 deemed significant. The chi-squared test of independence was used to evaluate the null hypothesis between the NGT and T2DM groups for categorical variables. Pearson's correlation was used to evaluate associations amongst imaging parameters.
Spearman's correlation was used to assess associations between LV diastolic function and metabolic parameters, which failed the normality test. The bias and limits of agreement (LoA) between imaging methods were obtained by the Bland-Altman analysis. 30 Multivariate linear regression analysis was conducted by stepwise multiple linear regression with E/A, as the dependent variable and HbA1c, fasting glucose, BMI, per cent body fat, plasma triglyceride, HDL and systolic blood pressure as the independent variables. 31 Logarithmic transformation was used on parameters whose distributions were deemed non-normal. The Tukey's ladder transformation process was used for variables that did not fit a non-normal distribution following logarithmic transformation. 
TA B L E 1 Characteristics of study population
Patient parameter NGT (N = 21) T2DM (N = 19) P-value
| RE SULTS
The clinical and metabolic characteristics of the study population are presented in Table 1 . All subjects had either normal LVDF values (E/A ≥ 0.8, septal e′ ≥8, lateral e′ ≥10, deceleration time 140 to 240 ms) or Grade 1, mildly impaired LVDF (E/A < 0.8, septal e′ <8, lateral e′ <10, deceleration time >240 ms). T2DM and NGT subjects were well matched for age and gender. BMI, per cent body fat and waist circumference were higher in T2DM vs NGT subjects. T2DM subjects had reduced plasma HDL cholesterol and higher plasma triglyceride levels compared to NGT subjects. Systolic and diastolic blood pressure was slightly higher in T2DM subjects compared to NGT individuals.
On mean, T2DM subjects were in reasonably good glycemic control as documented by HbA1c = 7.1 ± 1.4% (range = 5.3%-10.6%).
| LV systolic function
LV systolic functional measurements by TTE (Table 2 ) and CMRI ( Figure   S2A ). However, LV myocardial mass measurements were comparable by TTE and CMRI (bias = 0.66 g·m −2 , LoA: −1.84-0.53 g·m −2 ; Figure S2B ).
| LV diastolic function
Doppler measurements by echocardiography and flow assessment by CMRI showed that the E/A ratio measured by both methods was significantly decreased in T2DM vs NGT subjects (Tables 3 and 4 for diastolic dysfunction but was significantly lower in T2DM vs NGT (Table 4) . Doppler tissue velocity measurements showed that a septal peak e′ in T2DM (9.2 ± 1.3 cm/s) was lower than in NGT (12.6 ± 2.5 cm/s, P < .01) and that the E/e' ratio (8.7 ± 2) in T2DM was higher than in NGT (6.8 ± 1.5, P < .0001). Peak atrial velocity (PVAr) (reflects retrograde pressure over the pulmonic veins secondary to increased pressure in left atrium) was significantly greater in T2DM (26.1 ± 4.6 cm/s) vs NGT (22.2 ± 3.9 cm/s, P < .01).
| Correlations with diastolic function
Data from the NGT and T2DM groups were combined to determine correlations of diastolic function and metabolic parameters. Combining these data produced inherently bimodal data sets. Therefore, HbA1c, FPG, DecT by CMR and E/A by TTE data did not have normal distributions across both groups. E/A by CMRI was significantly and negatively correlated with HbA1c (ρ = −.61, P = .00003) and with FPG (r = −.60, P = .00004; Figure 1A ,B). E/A by TTE also was significantly and negatively correlated with HbA1c (ρ = −.49, P < .001) and FPG (ρ = −.51, P = .0008; Figure 2A ,B). DecT by CMRI was significantly correlated with FPG (ρ = .38, P = .02) but not HbA1c (ρ = .24, P = .15), while DecT obtained by TTE was significantly correlated with both HbA1c (ρ = .38, P = .015) and FPG (ρ = .46, P = .002; Figure 3A ,B). EDV/BSA by CMRI was significantly and negatively correlated with HbA1c (ρ = −.59, P = .00007) and FPG (ρ = −.42, P < .01; Figure 4A ,B). EDV/BSA by Data are presented as mean ± SD.
TA B L E 4 Echocardiographic Doppler flow and Doppler tissue parameters
F I G U R E 1 A, E/A values obtained by phase-contrast CMRI were significantly and negatively correlated with both HbA1c (ρ =−.61, P < .0001) and B, fasting plasma glucose. (ρ = −. 60, P < .0001) Blue squares indicate NGT subjects and red circles indicate T2DM subjects TTE was significantly and negatively correlated with HbA1c (ρ = −.56, P = .00016) and with FPG (ρ = −.37, P = .019). The mitral septal peak velocity (e') was significantly and negatively correlated with HbA1c
(ρ = −.58, P < .001) and FPG (ρ = −.74, P = .00004; Figure 5A ,B). E/A by CMRI was significantly and negatively correlated with FFA (ρ = −.47, P = .02) and DecT obtained by TTE was significantly correlated with FFA (ρ = .44, P = .005). Because hypertension has been shown to be related to the development of diastolic dysfunction, 34 we looked for correlations between both systolic and diastolic blood pressure and E/A, DecT, and EDV/VSA but none were found (P > .50). This is not surprising as blood pressure, although high in T2DM vs NGT, was only minimally increased (123/79 vs 115/75; Table 1 ). Because T2DM subjects were more obese than NGT individuals, we also looked for correlations between measures of obesity (BMI, % body fat, and waist circumference) and indices of diastolic function, but failed to observe any significant relationships (P > .30).
| Multivariate linear regression analysis
In a linear multivariate regression model with E/A as the dependent variable and HbA1c, fasting plasma glucose, BMI, per cent body fat, plasma triglyceride, HDL, and systolic blood pressure as the independent variables, only glucose control was significantly predictive of E/A. When HbA1c was included as a measure of glucose control, it was a significant predictor of E/A (P = .04); HDL and FFA were close to significance (P = .08). (Table 5 
| D ISCUSS I ON
The present study demonstrates that: (i) even reasonably wellcontrolled T2DM patients (mean A1c = 7.1%) manifest evidence of impaired LV diastolic function despite completely normal LV systolic function. All subjects had normal systolic function, with EF > 50%
by CMRI and EF > 60% by TTE; (ii) in the NGT group, most diastolic parameters fell within normal range; (iii) impaired diastolic function was associated with the level of glycemic control, as determined by the HbA1c and fasting plasma glucose concentration. The E/A ratio, by both imaging modalities, was significantly lower in T2DM vs NGT, while the DecT values, measured with both modalities, were significantly increased in T2DM vs NGT. The PLVFR/BSA also was lower in the T2DM group, while the E/e' ratio was significantly higher in T2DM; the PLVR/BSA correlated inversely with HbA1c (r = −.31, P < .05). Both the end-diastolic volume ( Figure 4 ) and e' (Figure 5 ) . 19, 35 In the current study, four NGT subjects and 17 T2DM subjects met the E/e′ threshold for diastolic dysfunction.
As multiple parameters documented that diastolic function in the T2DM group was compromised compared to the control NGT group, we characterize this condition as "impaired diastolic dysfunction" to mimic the prediabetic state "impaired glucose tolerance." This observation has important potential clinical observations as it may allow the clinician to identify those T2DM individuals with normal LV systolic function who are at risk to develop clinically significant diastolic dysfunction and diastolic heart failure.
As discussed previously, several imaging parameters were significantly and negatively correlated with HbA1c and FPG, including E/A, EDV/BSA and e', while DecT was significantly and positively correlated with HbA1c and FPG levels. Thus, glycemic control was associated with impaired diastolic function in T2DM individuals even though the level of glycemic control (mean HbA1c = 7.1%) was reasonably good according to goals established by the American Diabetes Association. 36 Although the mean HbA1c was 7.1%, the HbA1c range extended from 5.3% to 10.6%. Whether one uses the E/A ratio or the deceleration time (Figures 1 and 3) , it is clear that even individuals with an HbA1c ≤ 7.0% manifest a decline in diastolic function. Previous studies have demonstrated that diastolic function is abnormal in T2DM subjects, but these studies primarily included T2DM patients with more severe heart disease and poor glycemic control. 37, 38 The present study demonstrates that impaired LV diastolic function is evident even in well-controlled T2DM patients.
The triglyceride/HDL ratio, an index of insulin resistance, has been shown to be weakly correlated with diastolic dysfunction in insulintreated T2DM patients. 39 However, in the present study, neither the triglyceride/HDL ratio nor the triglyceride or HDL concentrations individually correlated with any parameter of diastolic function.
Hypertension also has been shown to be associated with diastolic dysfunction. 33 In the present study, we failed to observe any correlation between systolic or diastolic blood pressure and any index of diastolic function. However, it should be noted that the blood pressure was very well controlled in the diabetic group. We also failed to find a correlation between any measure of obesity (BMI, per cent body fat, and waist circumference) and any parameter of diastolic function.
Lastly, in the multivariate linear regression analysis, only glycemic control parameters (ie, HbA1c and FPG) were found to be significant predictors of E/A, suggesting that glycemic control is related to 
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TA B L E 5 Results of multivariate analysis with E/A as the dependent variable resulted in r 2 = .35 (P = .0003) 
